FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited (ANDA202230), authorizing the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)